RiverFront Investment Group LLC Acquires 1,161 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

RiverFront Investment Group LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 20,985 shares of the healthcare conglomerate’s stock after acquiring an additional 1,161 shares during the quarter. RiverFront Investment Group LLC’s holdings in UnitedHealth Group were worth $11,048,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $26,000. Robbins Farley acquired a new stake in UnitedHealth Group during the third quarter worth $25,000. CGC Financial Services LLC boosted its stake in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its stake in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its stake in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

UNH stock traded up $1.49 during midday trading on Friday, reaching $495.35. The stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The business has a fifty day simple moving average of $485.84 and a two-hundred day simple moving average of $514.14. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market cap of $455.76 billion, a price-to-earnings ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the company earned $6.26 EPS. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Morgan Stanley cut their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Finally, Truist Financial reissued a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.